Chemistry:Sodium orthovanadate
| File:Na3VO4dihydrate.tif | |
| Names | |
|---|---|
| IUPAC name
Sodium vanadate(V)
| |
| Other names
Sodium vanadium oxide
| |
| Identifiers | |
| |
3D model (JSmol)
|
|
| 12153548 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| 38128 | |
PubChem CID
|
|
| RTECS number |
|
| UNII | |
| |
| |
| Properties | |
| Na 3VO 4 | |
| Molar mass | 183.908 g/mol |
| Appearance | white powder |
| Density | 2.16 g/cm3, solid |
| Melting point | 858 °C (1,576 °F; 1,131 K) |
| 22.17 g/100 mL | |
| Solubility | insoluble in ethanol |
| Structure | |
| cubic | |
| Thermochemistry | |
Heat capacity (C)
|
164.8 J/mol K |
Std molar
entropy (S |
190 J/mol K |
Std enthalpy of
formation (ΔfH⦵298) |
−1757 kJ/mol |
| Hazards | |
| GHS pictograms | |
| GHS Signal word | Warning |
| HH302Script error: No such module "Preview warning".Category:GHS errors, HH312Script error: No such module "Preview warning".Category:GHS errors, HH332Script error: No such module "Preview warning".Category:GHS errors | |
| PP261Script error: No such module "Preview warning".Category:GHS errors, PP264Script error: No such module "Preview warning".Category:GHS errors, PP270Script error: No such module "Preview warning".Category:GHS errors, PP271Script error: No such module "Preview warning".Category:GHS errors, PP280Script error: No such module "Preview warning".Category:GHS errors, PP301+P317Script error: No such module "Preview warning".Category:GHS errors, PP302+P352Script error: No such module "Preview warning".Category:GHS errors, PP304+P340Script error: No such module "Preview warning".Category:GHS errors, PP317Script error: No such module "Preview warning".Category:GHS errors, PP321Script error: No such module "Preview warning".Category:GHS errors, PP330Script error: No such module "Preview warning".Category:GHS errors, PP362+P364Script error: No such module "Preview warning".Category:GHS errors, PP501Script error: No such module "Preview warning".Category:GHS errors | |
| NFPA 704 (fire diamond) | |
| Flash point | Non-flammable |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
330 mg/kg (oral, rat) |
| Related compounds | |
Related compounds
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Sodium orthovanadate is the inorganic compound with the chemical formula Na
3VO
4. It forms a dihydrate Na
3VO
4 · 2H2O. Sodium orthovanadate is a salt of the VO3−
4 oxyanion. It is a colorless, water-soluble solid.[2]
Synthesis and structure
Sodium orthovanadate is produced by dissolving vanadium(V) oxide in a solution of sodium hydroxide:
- V
2O
5 + 6 NaOH → 2 Na
3VO
4 + 3 H
2O
The salt features tetrahedral VO3−
4 anion centers linked to octahedral Na+
cation sites.[3]
Condensation equilibria
Like many oxometalates, orthovanadate is subject to a number of reactions, which have been analyzed by 51V NMR studies. At high pH, VO3−
4 ions exist in equilibrium with HVO2−
4.[4] At lower pH's, condensation ensues to give various polyoxovanadates. Ultimately, decavanadate is formed.[5]
Biochemistry
Vanadates exhibit a variety of biological activities, in part because they serve as structural mimics of phosphates.[6][7] It acts as a competitive inhibitor of ATPases, alkaline and acid phosphatases, and protein-phosphotyrosine phosphatases,[8] and its inhibitory effects can be reversed by dilution or the addition of ethylenediaminetetraacetic acid (EDTA).[9]
Orthovanadate is activated by boiling and adjusting pH to ~10; this depolymerizes decavanadate into the active inhibitor, monovanadate.[8]
References
- ↑ PubChem. "Sodium orthovanadate" (in en). https://pubchem.ncbi.nlm.nih.gov/compound/61671.
- ↑ Greenwood, Norman N.; Earnshaw, Alan (1997). Chemistry of the Elements (2nd ed.). Butterworth-Heinemann. ISBN 978-0-08-037941-8.
- ↑ Kato, K.; Takayama-Muromachi, E. (1987). "Die Struktur des Trinatriumvanadattrihydrats". Acta Crystallogr. C43 (6): 1030–1032. doi:10.1107/S0108270187093120. Bibcode: 1987AcCrC..43.1030K. http://journals.iucr.org/c/issues/1987/06/00/a27117/a27117.pdf.
- ↑ Rehder, D.; Polenova, T.; Bühl, M. (2007). Vanadium-51 NMR. Annual Reports on NMR Spectroscopy. 62. pp. 49–114. doi:10.1016/S0066-4103(07)62002-X. ISBN 9780123739193.
- ↑ Klemperer, W. G.; Yaghi, O. (1983). Tetrabutylammonium Trihydrogen Decavanadate(V). 27. 83. doi:10.1002/9780470132586.ch15.
- ↑ Korbecki, Jan; Baranowska-Bosiacka, Irena; Gutowska, Izabela; Chlubek, Dariusz (2012). "Biochemical and medical importance of vanadium compounds". Acta Biochim. Pol. 59 (2): 195–200. doi:10.18388/abp.2012_2138. PMID 22693688. http://www.actabp.pl/pdf/2_2012/195.pdf.
- ↑ Crans, D. C.; Chatterjee, P. B. (2013). "Comprehensive Inorganic Chemistry II: From Elements to Applications". in Reedijk, Jan; Poeppelmeier, Kenneth. Comprehensive Inorganic Chemistry II. 3. pp. 323–342. doi:10.1016/B978-0-08-097774-4.00324-7. ISBN 978-0-08-097774-4.
- ↑ 8.0 8.1 "Sodium orthovanadate". https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/1/s6508pis.pdf.
- ↑ Biolabs, New England. "Sodium Orthovanadate (Vanadate) | NEB" (in en). https://www.neb.com/products/p0758-sodium-orthovanadate-activated-vanadate#Product%20Information.

